ClinicalTrials.gg
CompletedNCT04908774KiWu-BUpdated Dec 29, 2023

Effects of a Fasting Mimicking Diet on Sperm Quality

An interventional study of Fasting Mimicking Diet in Sub Fertility, Male, Fertility Disorders and Sperm Count, Low, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to male participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-12-29.

Primary conditionOligospermiaRegistry: Infertility, MaleReclassifiedWhy we changed it
Registry
Infertility, Male — the first condition term the registry derived for this study.
ClinicalTrials.gg
Oligospermia
Why
  1. The study's listed conditions name Oligospermia, a narrower term within Infertility, Male.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Male
01

Study summary

This study investigates the effect of repetitive cycles of a Fasting Mimicking Diet (3x5 days in six months) on sperm quality in men

Read the detailed description

This 2-arm, randomized, controlled exploratory clinical trial aims to explore fasting as a novel supportive treatment in male infertility due to reduced sperm quality according to WHO5-criteria. The participants will be randomized in two groups. The intervention group follows a regime of a periodic fasting mimicking diet (3x5 days in six months, every 6-8 weeks, accompanied via a mobile application), whereas the patients on the waiting list continue their normal diet. Spermiograms are taken about every 2 months following the WHO-5 criteria. In addition, qualitative interviews will be conducted including individual and focus group interviews with a subgroup of participants.

02

Conditions studied

  • Sub Fertility, Male
  • Fertility Disorders
  • Sperm Count, Low

Browse trials for

Keywords

  • fasting
  • natural therapies
  • fasting mimicking diet
  • caloric restriction
  • dietary restriction
  • dietary intervention
  • lifestyle modification
  • spermiogram
  • sperm motility
  • liquefaction time
  • sperm morphology
  • total sperm count
  • sperm density
03

In context

Oligospermia Reclassified

64 studies on the registry are indexed under Oligospermia; 17 are open to participants now.

This study's enrollment of 22 is below the median of 65 across 46 interventional studies indexed under Oligospermia.

Browse Oligospermia studies →

Lead sponsor

Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 129 are open to participants now.

Compared within Oligospermia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Infertility, Male. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men aged between 18 and 60 years
  • Unfulfilled desire to have a child > 1 year
  • reduced sperm quality (proven via spermiogram according tho WHO-5 criteria)
  • 20 kg/m² \<= \<= 35 kg/m²

Exclusion criteria

Exclusion Criteria:

  • No sufficient communication possible
  • severely impairing cognitive illness
  • serious mental illness
  • Patients with anatomical/organic damage of reproductive organs
  • Eating disorders in the medical history
  • Serious internal diseases
  • Lack of internet access
  • No consent to randomisation
  • Participation in other studies
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Fasting Mimicking Diet Group

    The intervention group follows a fasting mimicking diet for 5 days every 6-8 weeks (a total of 3 times in 5 months).

    Behavioral: Fasting Mimicking Diet

  • No intervention
    Control Group

    This group maintains their individual diet during the whole time of the study. After 6 months they are offered a fasting intervention.

Interventions

  • BehavioralFasting Mimicking Diet

    The mobile application "Salufast" provides standardised fasting packages for 5 days of approx. 500 kcal and accompanies the participants during all fasting days.

    Also known as: Fasting, Dietary Intervention

06

What researchers measure

Primary outcomes

  1. Change in Total sperm motility

    WHO-5 spermiogram parameter to measure sperm quality

    Time frame: change from baseline to 6 months after baseline

  2. Qualitative interview analysis

    individual and focus group interviews

    Time frame: up to 48 weeks after fasting intervention

Secondary outcomes

  1. spermiogram following the WHO-5 criteria

    WHO-5 measurement of sperm quality

    Time frame: baseline and approx. every 2 months over the course of a year (12 months)

  2. quality of life according to the WHO-Five Well-Being Index

    WHO-5 questionnaire, validated questionnaire to evaluate the quality of life. It includes 5 questions that assess feelings or moods over the past two weeks. The items in this questionnaire are scaled on a six-point scale. The 5 items result in a total score from a minimum of zero to a maximum of 25, whereby a total score of less than 13 or a score of zero as an answer to one of the questions indicates a possible depression.

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  3. mindfulness

    MAAS-questionnaire, validated questionnaire to examine mindfulness. It consists of 14 items with four-point Likert scales (never, almost never, sometimes, often, very often). A sum score is formed by adding them up.

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  4. anxiety and depression

    HADS-questionnaire, validated questionnaire to examine anxiety and depression. The HADS-D is used to assess anxiety and depression in patients with physical diseases or (possibly psychogenic) physical complaints. It measures the degree of anxiety and depressive symptoms during the past week by means of self-report, which is recorded on two subscales with seven items each. The total score can be used as a measure of general psychological impairment.

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  5. current mood

    ASTS-questionnaire, validated questionnaire to examine current mood.The "Profile of Mood States" served as the basis for the contruction. The ASTS comprises 19 items on five subscales: sadness, hopelessness, fatigue, anger and positive mood.

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  6. experienced stress

    Cohen-stress scale, validated questionnaire to examine experienced stress. Cohen Perceived Stress Scale (CPSS): The CPSS measures the degree of acute subjective experience of stress (Cohen 1983). It consists of 14 items with four-point Likert scales (never, almost never, sometimes, often, very often). A sum score is formed by summing up the items.

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  7. physical fitness

    questionnaire to examine physical fitness

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  8. Changes in diet

    questionnaire to examine diet

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  9. quality of relationship

    questionnaire to examine the relationship between the two partners desiring to have a child

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  10. psychological stress caused by the unfulfilled desire to have children

    questionnaire to examine the psychological stress caused by the unfulfilled desire to have children

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  11. gratitude

    validated questionnaire to examine gratitude

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

  12. self-efficacy

    ASKU, validated questionnaire to examine self-efficacy. The ASKU with three items is used for the economic measurement of subjective competence expectations. It includes the psychological variables self-esteem, internal locus of control, global life satisfaction, optimism as well as the personality traits neuroticism and extraversion from the five-factor model

    Time frame: baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks

Other outcomes

  1. liver sonography

    sonography in a subgroup

    Time frame: up to 14 days before, during and up to 14 days after a fasting intervention

  2. reported pregnancy of female partner

    questionnaire

    Time frame: up to 12 months after baseline

07

Study locations

1 site
  • Hochschulambulanz für Naturheilkunde der Charité-Universitätsmedizin Berlin
    Berlin, 14109, Germany
08

References and documents

Individual participant data

Plan to share: Yes — Data will be made available upon request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: after the end of the study for 5 years

Access criteria: on demand

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04908774
Collaborators
Karl and Veronica Carstens Foundation
Responsible party
Andreas Michalsen (Prof. Dr. med., Charite University, Berlin, Germany) — Principal investigator
First posted
Jun 1, 2021
Start date
May 25, 2021
Primary completion
Oct 1, 2023
Completion
Oct 1, 2023
Last update
Dec 29, 2023

Study contacts

Andreas Michalsen, Prof. Dr.
principal investigator · Charite University, Berlin, Germany

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion